medigraphic.com
ISSN 2078-7170 (Electronic)

2013, Number 3

<< Back Next >>

CorSalud 2013; 5 (3)

Use of temporary cardiac pacing, its complications and need for permanent cardiac pacing

Mortera OME, Chávez GE, Rodríguez GF, Alonso HA, Ramírez GJI, Ramos GH

Language: Spanish
References: 25
Page: 261-268
PDF size: 399.78 Kb.


ABSTRACT

Introduction: Temporary cardiac pacing is used in various extreme emergency situations, in patients with severe bradyarrhythmias and second and third degree atrioventricular block. Its use is always considered when there are symptoms such as a significant hemodynamic compromise, not responding to medication, and little tolerance to slow pace.
Objective: To describe the main use of temporary cardiac pacing that may lead to permanent pacing, and the complications that arise when using it.
Method: A descriptive study was conducted in 266 of the 281 patients who were admitted to the "Arnaldo Milian" Castro Hospital and received a temporary pacemaker. The use and complications of the procedure are described.
Results: There was a higher use of temporary cardiac pacing as the age of the study population increased, 45.86% for those over 80 years of age. Females predominated (156 patients), with a female-male ratio of 1.56:1. The degenerative cause (42.1%) was the major cause for permanent pacing. The puncture of unwanted vessels was the most common complication (7.1%).
Conclusions: The use of temporary cardiac pacing is more common in people over 80 years of age, mainly because of degenerative causes, which eventually leads to permanent pacing. The complication rate is not high considering that this procedure was not performed under fluoroscopic view.


REFERENCES

  1. Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: the task force for cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology. De-veloped in collaboration with the European Heart Rhythm Association. Eur Heart J. 2007;28(18):2256-95.

  2. Santamaría Fuentes SJ, García Gómez A, León Ro-bles M, Coca Machado JL, Hernández Torres A. Uso de marcapasos temporales intracavitarios en el infarto agudo del miocardio. Rev Cub Med Int Emerg [Internet]. 2008 [citado 3 Oct 2013];7(1): [aprox. 5 p.]. Disponible en: http://www.bvs.sld.cu/revistas/mie/vol7_1_08/mie02108.htm

  3. Coma Samartín R, de Blas Carbonell R, Castaño Ruiz M. Estimulación cardíaca temporal. Estimulación tras la cirugía cardíaca. Rev Esp Cardiol. 2007;7(7): 54G-68G.

  4. Matarama Peñate M, LLanio Navarro R, Muñiz Iglesias P, Quintana Setién C, Hernández Zúñiga R, Vicente Peña E. Indicaciones de marcapasos tran-sitorios. En: Medicina Interna. Diagnóstico y trata-miento. La Habana: ECIMED; 2005. p. 175-216.

  5. Martínez Peralta M. Marcapasos en situaciones emergentes. En: Caballero LA. Terapia Intensiva. Vol. 2. 2da ed. La Habana: ECIMED; 2006. p. 752-3.

  6. García Calabozo R, Martínez Ferrer J, Sancho-Tello de Carranza MJ. Temas de actualidad de estimula-ción cardiaca. Rev Esp Cardiol. 2006;59:66-77.

  7. López Ayerbe J, Villuendas Sabaté R, García García C, Rodríguez Leor O, Gómez Pérez M, Curós Abadal A, et al. Marcapasos temporales: utilización actual y complicaciones. Rev Esp Cardiol. 2004;57:1045-52.

  8. García Jiménez A. Implantación de marcapasos transitorios: resultados y complicaciones. REMI [Internet]. 2004 [citado 5 Ene 2009];4(12):[aprox. 3 p.]. Disponible en: http://remi.uninet.edu/2004/12/REMI0810.htm

  9. Moreno AM, Tomás JG, Alberola AG, Hernández JM, Fernández SR, Payá JF, et al. Significado pronóstico de la implantación de marcapasos transitorio en pacientes con infarto agudo de miocardio. Rev Esp Cardiol. 2001;54(8):949-57.

  10. 10.Braun MU, Rauwolf T, Bock M, Kappert U, Boscheri A, Schnabel A, et al. Percutaneous lead implanta-tion connected to an external device in stimulation-dependent patients with systemic infection – A prospective and controlled study. Pacing Clin Elec-trophysiol. 2006;29(8):875-9.

  11. 11.González ZJ. Primer curso de arritmias por Internet.Trastornos de conducción. Buenos Aires. Ar-gentina [Internet]. 2011 [citado 5 abril 2011: [aprox. 3p]. Disponible en: http://www.fac.org.ar/cvirtual/cvirtesp/cientesp/aresp/cursoesp/clase2/zuelga1.htm

  12. 12.Ardashev A, Dzhandzhgava A, Dvornikov A, Butaev T. Pacing therapy improves quality of life in AV conduction disturbances patients [Abstract]. Euro-pace. 2005;7(Suppl 3):S44.

  13. 13.Bethea BT, Salazar JD, Grega MA, Doty JR, Fitton TP, Alejo DE, et al. Determining the utility of temporary pacing wires after coronary artery bypass surgery. Ann Thorac Surg. 2005;79(1):104-7.

  14. 14.Betts T. Regional survey of temporary transvenous pacing procedures and complications. Postgrad Med J. 2003;79(934):463-6.

  15. 15.Martínez-Sellés M. ¿Qué tienen las mujeres en el corazón?. Rev Esp Cardiol. 2007; 60(11):1118-21.

  16. 16.Muñoz Bono J, Prieto Palomino MA, Macías Gua-rasa I, Hernández Sierra B, Jiménez Pérez G, Curiel Balsera E, et al. Eficacia y seguridad de la implan-tación de marcapasos transvenosos transitorios en una unidad de cuidados intensivos. Med Intensiva. 2011;35(7):460-98.

  17. 17.Grupo de Trabajo de la Sociedad Europea de Cardiología (ESC) sobre el manejo del infarto agudo de miocardio con elevación del segmento ST (IAMCEST). Guías de Práctica Clínica de la Sociedad Europea de Cardiología (ESC). Manejo del infarto agudo de miocardio en pacientes con elevación persistente del segmento ST. Rev Esp Cardiol. 2009; 62(3):e1-e47.

  18. 18.Winner S, Boon N. Clinical problems with tem-porary pacemakers prior to permanent pacing. J R Coll Physicians Lond. 1989;23(3):161-3.

  19. 19.Murphy JJ. Current practice and complications of temporary transvenous cardiac pacing. BMJ. 1996; 312(7039):1134.

  20. 20.Jou YL, Hsu HP, Tuan TC, Wang KL, Lin YJ, Lo LW, et al. Trends of temporary pacemaker implant and underlying disease substrate. Pacing and Clinical Electrophysiology. 2010;33(12):1475-84.

  21. 21.Morgan G, Ginks W, Siddons H, Leatham A. Septi-cemia in patients with an endocardial pacemaker. Am J Cardiol. 1979;44(2):221-4.

  22. 22.Choo MH, Holmes DR, Gersh BJ, Maloney JD, Meri-deth J, Pluth JR, et al. Permanent pacemaker infec-tions: characterization and management. Am J Car-diol. 1981;48(3):559-64.

  23. 23.McCann P. A review of temporary cardiac wires. In-dian Pacing Electrophysiol J. 2007;7(1):40-9.

  24. 24.Birkhahn RH, Gaeta TJ, Tloczkowski J, Mundy T, Sharma M, Bove J, et al. Emergency medicine-trained physicians are proficient in the insertion of transvenous pacemakers. Ann Emerg Med. 2004; 43(4):469-74.

  25. 25.Harrigan RA, Chan TC, Moonblatt S, Vilke GM, Ufberg JW. Temporary transvenous pacemaker placement in the Emergency Department. J Emerg Med. 2007;32(1):105-11.




2020     |     www.medigraphic.com